NIH R01 · 2024
Project Summary/Abstract There are over 900 drugs and drug combinations currently in clinical trials for COVID-19. While this pace of drug development is necessary, it also comes with increased risk of producing therapies with significant side- effects. One likely side-effect of some COVID-19 drugs is hearing loss. The potential of drugs to cause hearing loss is typically unassessed during drug development or clinical testing. Our research will rapidly assess COVID-19 drugs for ototoxic potential, as per NOT-DC-20-008 to determine the “Potential ototoxicity from therapeutics or vaccination related to COVID-19.” Our goal is to promote the development of safe COVID-19 drugs with minimal side…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.